Together we will beat cancer

Donate

Scientists developing new class of drug for leukaemia

Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year. 

Read More

Mutations in overlooked DNA could have profound impact on bowel cancer survival

DNA errors in the cell’s energy ‘factories’ increases the chances of survival for people with bowel cancer, according to a new study.

Read More

An unexpected find: clues about the genetics of children’s cancer found in the placenta

Scientists at the Wellcome Sanger Institute have discovered that that genetic structure of the placenta contains many of the same genetic mutations found in children’s cancers.

Read More

New link between high testosterone in men and increased risk of melanoma

Researchers have uncovered a new link between higher levels of testosterone in the blood and increased risk of melanoma skin cancer in men.

Read More

‘A significant step forwards’ – treating patients with advanced biliary tract cancers

An existing combination of chemotherapy could be used to provide a new option for biliary tract cancer patients.

Read More

Predicting future breast cancer with precision

This entry is part 26 of 26 in the series Cancer Grand Challenges

An international team of Cancer Grand Challenges scientists are conducting one biggest studies of its kind to try to predict who will develop invasive breast cancer.

Read More

How does processed and red meat cause cancer and how much matters?

How does bacon cause cancer? Research shows that moderate processed and red meat eating increases bowel cancer risk.

Read More

Could proton beam therapy improve throat cancer treatment?

The first proton beam therapy clinical trial in the UK is finding out if this innovative new form of radiotherapy can improve throat cancer treatment.

Read More

Changes detected in BRCA1 breast cells before they turn cancerous

Scientists have mapped out some of the earliest changes that occur in seemingly healthy breast tissue long before any tumours appear.

Read More

How repurposing a drug in a COVID-19 trial could benefit people with cancer

We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.

Read More